371 related articles for article (PubMed ID: 32724454)
1. Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.
Li Y; Liu R; Wu J; Li X
Theranostics; 2020; 10(18):7993-8017. PubMed ID: 32724454
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis.
Zheng H; Yang Z; Xin Z; Yang Y; Yu Y; Cui J; Liu H; Chen F
Theranostics; 2020; 10(25):11737-11753. PubMed ID: 33052244
[TBL] [Abstract][Full Text] [Related]
3. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
Zou M; Wang F; Gao R; Wu J; Ou Y; Chen X; Wang T; Zhou X; Zhu W; Li P; Qi LW; Jiang T; Wang W; Li C; Chen J; He Q; Chen Y
Sci Rep; 2016 Apr; 6():24747. PubMed ID: 27098600
[TBL] [Abstract][Full Text] [Related]
4. The controversial role of mast cells in fibrosis.
Bradding P; Pejler G
Immunol Rev; 2018 Mar; 282(1):198-231. PubMed ID: 29431218
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-β1 driven epithelial-to-mesenchymal transition.
Prashanth Goud M; Bale S; Pulivendala G; Godugu C
Int Immunopharmacol; 2019 Oct; 75():105755. PubMed ID: 31377591
[TBL] [Abstract][Full Text] [Related]
6. MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2.
Han R; Ji X; Rong R; Li Y; Yao W; Yuan J; Wu Q; Yang J; Yan W; Han L; Zhu B; Ni C
J Mol Med (Berl); 2016 Nov; 94(11):1267-1279. PubMed ID: 27351886
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy.
He Y; Lu R; Wu J; Pang Y; Li J; Chen J; Liu B; Zhou Y; Zhou J
Biomed Pharmacother; 2020 Aug; 128():110241. PubMed ID: 32450523
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury.
Lu H; Chen B; Hong W; Liang Y; Bai Y
FEBS J; 2016 Oct; 283(20):3771-3790. PubMed ID: 27579669
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases.
Takuwa Y; Ikeda H; Okamoto Y; Takuwa N; Yoshioka K
Biochim Biophys Acta; 2013 Jan; 1831(1):185-92. PubMed ID: 22735357
[TBL] [Abstract][Full Text] [Related]
11. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
Deng YL; Xiong XZ; Cheng NS
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
[TBL] [Abstract][Full Text] [Related]
12. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
Guarino M; Tosoni A; Nebuloni M
Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
[TBL] [Abstract][Full Text] [Related]
13. Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI.
Patschan D; Schwarze K; Henze E; Patschan S; Müller GA
J Nephrol; 2016 Oct; 29(5):637-44. PubMed ID: 26289253
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory role of interleukin-35 in fibrotic diseases.
Luo M; Peng H; Chen P; Zhou Y
Expert Rev Clin Immunol; 2019 Apr; 15(4):431-439. PubMed ID: 30590954
[TBL] [Abstract][Full Text] [Related]
15. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z
Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732
[TBL] [Abstract][Full Text] [Related]
16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-inducing natural compounds: a treasure resource for developing therapeutics against tissue fibrosis.
Lv XX; Liu SS; Hu ZW
J Asian Nat Prod Res; 2017 Feb; 19(2):101-108. PubMed ID: 28252344
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ENST00000453774.1 contributes to oxidative stress defense dependent on autophagy mediation to reduce extracellular matrix and alleviate renal fibrosis.
Xiao X; Yuan Q; Chen Y; Huang Z; Fang X; Zhang H; Peng L; Xiao P
J Cell Physiol; 2019 Jun; 234(6):9130-9143. PubMed ID: 30317629
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy.
Bao J; Shi Y; Tao M; Liu N; Zhuang S; Yuan W
Clin Sci (Lond); 2018 Nov; 132(21):2299-2322. PubMed ID: 30293967
[TBL] [Abstract][Full Text] [Related]
20. Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis.
Cabrera S; Maciel M; Herrera I; Nava T; Vergara F; Gaxiola M; López-Otín C; Selman M; Pardo A
Autophagy; 2015 Apr; 11(4):670-84. PubMed ID: 25906080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
